NEWS

We inform you about the current business development of HAEMATO AG and about our investor relations activities.

Ad-hoc disclosure under Art.17 MAR

Ad-hoc disclosure under Art.17 MAR

HAEMATO AG: Ad-hoc disclosure under Article 17 MAR HAEMATO AG: MPH Health Care AG brings its shares in HAEMATO AG to M1 Kliniken AG as part of a non-cash capital increase. Today MPH Health Care AG and M1 Kliniken AG informed us that MPH Health Care AG transfers all of...

read more
AGM postponement

AGM postponement

Due to the present imponderables HAEMATO AG will reschedule the Annual General Meeting originally intended on July 8, 2020 to a later date. Due to the current uncertainties around the COVID-19 pandemic the Executive Board and the Supervisory Board of HAEMATO AG,...

read more
Q1 2020 Results

Q1 2020 Results

HAEMATO AG, Berlin (ISIN: DE0006190705), published the annual report 2019 on May 11, 2020 as previously announced in the financial calendar. In the first quarter of 2020, the Group sales totalled EUR 60.6 million. HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS...

read more
Annual Report 2019

Annual Report 2019

HAEMATO AG, Berlin (ISIN: DE0006190705), published the annual report 2019 on May 11, 2020 as previously announced in the financial calendar. HAEMATO AG, Berlin (ISIN: DE0006190705), achieved IFRS consolidated sales of EUR 197.8 million (previous year: EUR 274.1...

read more
appropriation of profits

appropriation of profits

The Supervisory Board of HAEMATO AG (ISIN: DE0006190705) approved today’s proposal for the appropriation of profits by the Management Board in today’s balance sheet meeting. Accordingly, the management of the Annual General Meeting on July 8, 2020 will propose that the retained earnings for the 2019 financial year be carried forward to new account.

read more

HAEMATO AG

HAEMATO AG
Lilienthalstraße 5c
12529 Schönefeld
Germany

Phone: +49-30 897 30 86 70
Telefax: +49-30 897 30 86 79
E-Mail: info@haemato.ag